Condition
Carious Primary Molars Indicated for Pulpectomy
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
4 treatments under study, led by Iodoformcalcium Hydroxide Metapex
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Iodoformcalcium Hydroxide Metapex1
- Rotary Instrumentation1
- Zinc Oxide Eugenol Zoe1
- Manual Instrumentation1
Active Sponsors
- October University for Modern Sciences and Arts1